Navigation Links
In-hospital formula use deters breastfeeding
Date:2/14/2014

al breastfed group had stopped breastfeeding.

Perhaps most significant, in-hospital formula feeding dramatically reduced the likelihood of later fully breastfeeding as well as any breastfeeding, even after adjusting for the strength of the mothers' intention to continue these practices. Early formula use nearly doubled the risk of formula use from the first to the second month and nearly tripled the risk of ending all breastfeeding by the end of the second month.

The study also found that breastfeeding deterrence was dose dependent. In other words, the more formula given to babies during their hospital stay, the less likely the mother would continue breastfeeding. This is the first time researchers have found a relationship between in-hospital formula doses and breastfeeding behavior.

Mothers indicated a number of reasons for giving their babies formula in the hospital. Many thought they weren't producing enough milk. Some thought their babies weren't getting enough nutrition or were not latching on properly. Chantry notes that sometimes formula is medically necessary and research is needed to better understand how to minimize its negative effects on breastfeeding.

Chantry believes this research highlights the value of The Ten Steps to Successful Breastfeeding evidence-based guidelines to help mothers breastfeed. These include educating women about the benefits of breastfeeding, teaching them how to breastfeed and limiting formula use unless medically necessary.

"These results underline the importance of providing comprehensive support for women who wish to breastfeed," says Chantry. "Doctors and nurses must be trained to help, and lactation consultants must be readily available. We need to do more to help mothers overcome breastfeeding obstacles and limit formula use."

Breastfeeding exclusively rather than using infant formula is recommended for the first six months after birth by the American Academy o
'/>"/>

Contact: Tricia Tomiyoshi
tricia.tomiyoshi-marsom@ucdmc.ucdavis.edu
916-734-9706
University of California - Davis Health System
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. A touch of garlic helps kill contaminants in baby formula
2. DHA-enriched formula in infancy linked to positive cognitive outcomes in childhood
3. Xyngular Announces the Launch of its New Xyng Enhanced Formula
4. Formula-feeding linked to metabolic stress and increased risk of later disease
5. New formula invented for microscope viewing, substitutes for federally controlled drug
6. New, cost-cutting approach to formulating pest-killing fungi
7. UC Riverside developing biofuel formulations for California
8. Breast milk promotes a different gut flora growth than infant formulas
9. Maths formula leads researchers to source of pollution
10. Liquid glucagon formulation discovered for potential use in artificial pancreas systems
11. Hazelnuts improve infant formula
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Fingerprint Cards has received an order for its ... distributor World Peace Industrial Group (WPI), part of WPG Holdings. ... . Deliveries are planned to take place during Q3 ... manufacturers in Asia . The order value ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, ...
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical ... use solutions, headquartered in Springville, Utah , ... California corporation with locations in Santa ... Rica ). This acquisition will incorporate MedConx,s ... ATL Technology,s existing facility in Costa Rica ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... Polarstern has returned today to Bremerhaven from the Arctic ... ever both the Northeast and the Northwest Passages and ... the research vessel,s 23rd Arctic expedition, operated by the ... journey on August 12th in Reykjavik and ended it ...
... MADISON, WI, OCTOBER 20, 2008 -- The widespread use of ... decades, with little knowledge of the long-term effects on the ... study show that samples taken from over 300 wells across ... contamination. The news is a result of a decadal long ...
... LEDs may help ... Researchers in Germany are describing a potential alternative ... Their study, scheduled for the November 5 issue of ... journal, reports that high intensity visible light from light ...
Cached Biology News:Research around the North Pole 2Research around the North Pole 3Pesticide concentrations decreasing 2American Chemical Society Weekly PressPac Oct. 15, 2008 2American Chemical Society Weekly PressPac Oct. 15, 2008 3American Chemical Society Weekly PressPac Oct. 15, 2008 4American Chemical Society Weekly PressPac Oct. 15, 2008 5American Chemical Society Weekly PressPac Oct. 15, 2008 6American Chemical Society Weekly PressPac Oct. 15, 2008 7American Chemical Society Weekly PressPac Oct. 15, 2008 8
(Date:7/27/2015)... FRANKLIN, Tenn. , July 27, ... provider of health care services and one of ... today announced that its parent company and sole ... agreement with Medical Properties Trust, Inc. ("MPT") (NYSE: ... for $900 million in cash.  The transaction is expected to ...
(Date:7/27/2015)... ... July 27, 2015 , ... This is a professional and ... basic overview of the industry including definitions, classifications, applications and industry chain structure. ... competitive landscape analysis, and key regions development status. Development policies and plans are ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... announced a new video: 3 Ways to GHS Labels . This video ... the Globally Harmonized System (GHS) by effectively labeling chemical containers. , “With the ...
(Date:7/27/2015)... -- Research presented at the 2015 AACC Annual Meeting ... that led to a fingerprick Ebola test becoming the ... receive approval from the World Health Organization (WHO). This ... West Africa by identifying suspected ... isolate and treat these patients much faster than is ...
Breaking Biology Technology:Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 52015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Brady Releases “3 Roads to GHS Labels” Video 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3
... Boston Scientific,Corporation (NYSE: BSX ) today announced ... Drug Administration (FDA) to market its second-generation,TAXUS(R) Liberte(R) ... the TAXUS Liberte stent early next month in ... its TAXUS(R),Expresss2(TM) Atom(TM) Paclitaxel-Eluting Coronary Stent System, which ...
... Beike,Biotechnology Co. Ltd., ( http://www.beikebiotech.com ) ... through evidence-based medicine, announced,today it has signed eight ... the world,s most outstanding stem cell research organizations.,As ... a "Stem Cell Expert,Advisory Committee" and a separate ...
... WILMINGTON, Del., Oct. 10 AstraZeneca (NYSE:,AZN) today ... (FDA) has,approved once-daily SEROQUEL XR(R) (quetiapine fumarate) Extended-Release,Tablets ... associated with,bipolar disorder, the manic and mixed episodes ... of bipolar I disorder as adjunctive,therapy to lithium ...
Cached Biology Technology:Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 3Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9
ANTI END CEL LUNG AG...
EGTA, 50 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
RABBIT ANTI NEOPTERIN...
Biology Products: